- Report
- December 2022
Malta
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Ireland
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Iceland
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Hungary
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Portugal
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Poland
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Albania
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Bulgaria
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Russia
From €2219EUR$2,500USD£1,910GBP
- Report
- December 2022
Romania
From €2219EUR$2,500USD£1,910GBP
- Report
- July 2022
Global
From €30623EUR$34,500USD£26,356GBP
- Database
- January 2022
Ireland
From €1553EUR$1,750USD£1,337GBP
- Book
- April 2015
- 352 Pages

The Staphylococci market within the context of Infectious Disease Testing is a rapidly growing sector. Staphylococci are a group of bacteria that can cause a range of illnesses, from minor skin infections to life-threatening conditions such as sepsis. As such, testing for Staphylococci is an important part of diagnosing and treating infectious diseases. Tests for Staphylococci are used to identify the presence of the bacteria, as well as to determine the type of Staphylococci present. Tests can also be used to determine the susceptibility of the bacteria to antibiotics.
The Staphylococci market is driven by the increasing prevalence of infectious diseases, as well as the need for accurate and timely diagnosis. The market is also driven by advances in technology, which have enabled more accurate and rapid testing.
Companies in the Staphylococci market include Becton Dickinson, bioMérieux, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more